Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichi Tate

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|March 21, 2020
Metastatic peripancreatic lymph nodes resection during primary debulking surgery for primary peritoneal serous carcinomaKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 12, 2003
Early invasive cervical adenocarcinoma: its potential for nodal metastasis or recurrenceYasuo Hirai, Nobuhiro Takeshima, Shinichi Tate, et al.
Cancers|September 23, 2022
Serum FSH as a Useful Marker for the Differential Diagnosis of Ovarian Granulosa Cell TumorsAyumu Matsuoka, Shinichi Tate, Kyoko Nishikimi, et al.
Journal of Gynecologic Oncology|February 28, 2025
Intra- and postoperative complications associated with diaphragmatic surgery for advanced ovarian cancerKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
Journal of Gynecologic Oncology|November 13, 2020
Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trialShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Journal of Gynecologic Oncology|January 9, 2020
Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancerShinichi Tate, Kyoko Nishikimi, Kazuyoshi Kato, et al.
American Journal of Clinical Pathology|February 24, 2018
Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell CarcinomaKyoko Nishikimi, Kiyoshi Nakagawa, Shinichi Tate, et al.
Acta Cytologica|March 24, 2010
Cytologic findings of low grade endometrial stromal sarcoma with sex cord-like differentiation: a case reportKyoko Nishikimi, Nobuya Habuka, Yuko Okazima, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2016
Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II studyShinsuke Hanawa, Akira Mitsuhashi, Ayumu Matsuoka, et al.
Cancers|July 2, 2021
Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell CarcinomaShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|March 21, 2020
Metastatic peripancreatic lymph nodes resection during primary debulking surgery for primary peritoneal serous carcinomaKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 12, 2003
Early invasive cervical adenocarcinoma: its potential for nodal metastasis or recurrenceYasuo Hirai, Nobuhiro Takeshima, Shinichi Tate, et al.
Cancers|September 23, 2022
Serum FSH as a Useful Marker for the Differential Diagnosis of Ovarian Granulosa Cell TumorsAyumu Matsuoka, Shinichi Tate, Kyoko Nishikimi, et al.
Journal of Gynecologic Oncology|February 28, 2025
Intra- and postoperative complications associated with diaphragmatic surgery for advanced ovarian cancerKyoko Nishikimi, Shinichi Tate, Ayumu Matsuoka, et al.
Journal of Gynecologic Oncology|November 13, 2020
Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trialShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Journal of Gynecologic Oncology|January 9, 2020
Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancerShinichi Tate, Kyoko Nishikimi, Kazuyoshi Kato, et al.
American Journal of Clinical Pathology|February 24, 2018
Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell CarcinomaKyoko Nishikimi, Kiyoshi Nakagawa, Shinichi Tate, et al.
Acta Cytologica|March 24, 2010
Cytologic findings of low grade endometrial stromal sarcoma with sex cord-like differentiation: a case reportKyoko Nishikimi, Nobuya Habuka, Yuko Okazima, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2016
Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II studyShinsuke Hanawa, Akira Mitsuhashi, Ayumu Matsuoka, et al.
Cancers|July 2, 2021
Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell CarcinomaShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Pageof 6